Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
Tech Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shiftBy Healthcare Propulsion StaffJuly 30, 20260 Teladoc Health trimmed its 2026 revenue outlook as its virtual behavioral health unit, BetterHelp, faces revenue pressure with consumer demand…
